Home
NPCE
NPCE News

Latest Neuropace Inc. (NPCE) News on September 18, 2025

NeuroPace, Inc.'s (NASDAQ:NPCE) Intrinsic Value Is Potentially 99% Above Its Share Price

Simply Wall St.

8 days ago

NeuroPace, Inc.'s (NASDAQ:NPCE) Intrinsic Value Is Potentially 99% Above Its Share Price

NeuroPace Announces Strategic CFO Transition

GlobeNewswire

3 months ago

NeuroPace Announces Strategic CFO Transition

NeuroPace, Inc. (NPCE) Backed by Cantor Fitzgerald Following Physician Survey

Insider Monkey

3 months ago

NeuroPace, Inc. (NPCE) Backed by Cantor Fitzgerald Following Physician Survey

MT Newswires

3 months ago

NeuroPace Secures $75 Million Credit Facility From MidCap Financial

NeuroPace Secures Up to $75 Million in Debt Financing

GlobeNewswire

3 months ago

NeuroPace Secures Up to $75 Million in Debt Financing

H.C. Wainwright Initiates Coverage of NeuroPace (NPCE) With Buy Rating

Insider Monkey

4 months ago

H.C. Wainwright Initiates Coverage of NeuroPace (NPCE) With Buy Rating

NPCE Stock Tumbles Despite Positive One-Year Data From NAUTILUS Trial

Zacks

4 months ago

NPCE Stock Tumbles Despite Positive One-Year Data From NAUTILUS Trial

NeuroPace reports initial one-year outcomes from trial of RNS System

Medical Device Network

4 months ago

NeuroPace reports initial one-year outcomes from trial of RNS System

MT Newswires

4 months ago

HC Wainwright Initiates NeuroPace at Buy With $18 Price Target

MT Newswires

4 months ago

Top Midday Decliners

Why Is NeuroPace Stock Falling After Epilepsy Treatment Study Data?

Benzinga

4 months ago

Why Is NeuroPace Stock Falling After Epilepsy Treatment Study Data?

MT Newswires

4 months ago

NeuroPace Says Epilepsy Trial Meets Safety Goal, Misses Overall Efficacy Target

NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study

GlobeNewswire

4 months ago

NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study

5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil

Zacks

4 months ago

5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil

NeuroPace, Inc.'s (NASDAQ:NPCE) large institutional owners must be happy as stock continues to impress, up 29% over the past week

Simply Wall St.

4 months ago

NeuroPace, Inc.'s (NASDAQ:NPCE) large institutional owners must be happy as stock continues to impress, up 29% over the past week

NeuroPace First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

4 months ago

NeuroPace First Quarter 2025 Earnings: Beats Expectations

Thomson Reuters StreetEvents

4 months ago

Q1 2025 Neuropace Inc Earnings Call

GuruFocus.com

4 months ago

NeuroPace Inc (NPCE) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates

Zacks

4 months ago

NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates

Associated Press Finance

4 months ago

NeuroPace Inc.: Q1 Earnings Snapshot

NeuroPace Reports First Quarter 2025 Financial Results

GlobeNewswire

4 months ago

NeuroPace Reports First Quarter 2025 Financial Results

NeuroPace Inc (NPCE) Q1 2025 Earnings Report Preview: What To Look For

GuruFocus.com

4 months ago

NeuroPace Inc (NPCE) Q1 2025 Earnings Report Preview: What To Look For

MT Newswires

5 months ago

NeuroPace Reports 'Minimal impact' From Trump Tariffs

NeuroPace Provides Update on Tariff Status

GlobeNewswire

5 months ago

NeuroPace Provides Update on Tariff Status

NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting

GlobeNewswire

5 months ago

NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting

NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting

GlobeNewswire

5 months ago

NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting

MT Newswires

6 months ago

NeuroPace to End Stereo EEG Distribution Accord; 2025 Revenue Guidance Affirmed

NeuroPace Announces Refocusing of Product Portfolio

GlobeNewswire

6 months ago

NeuroPace Announces Refocusing of Product Portfolio

NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

6 months ago

NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference

NeuroPace Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

6 months ago

NeuroPace Full Year 2024 Earnings: EPS Beats Expectations

Thomson Reuters StreetEvents

6 months ago

Q4 2024 Neuropace Inc Earnings Call

GuruFocus.com

6 months ago

NeuroPace Inc (NPCE) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

Associated Press Finance

6 months ago

NeuroPace Inc.: Q4 Earnings Snapshot

NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

6 months ago

NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results

UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference

GlobeNewswire

7 months ago

UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference

NeuroPace to Present at the Leerink Partners Global Healthcare Conference

GlobeNewswire

7 months ago

NeuroPace to Present at the Leerink Partners Global Healthcare Conference

GuruFocus.com

7 months ago

NeuroPace Inc (NPCE) Q4 2024 Earnings Report Preview: What to Look For

NeuroPace (NPCE) Surges 5.8%: Is This an Indication of Further Gains?

Zacks

7 months ago

NeuroPace (NPCE) Surges 5.8%: Is This an Indication of Further Gains?

NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.

GlobeNewswire

7 months ago

NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.

Integer (ITGR) Misses Q4 Earnings Estimates

Zacks

7 months ago

Integer (ITGR) Misses Q4 Earnings Estimates

NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

GlobeNewswire

7 months ago

NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

7 months ago

NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

MT Newswires

7 months ago

Update: NeuroPace Prices $65 Million Public Offering; Shares Jump

MT Newswires

7 months ago

Sector Update: Health Care Stocks Flat to Higher Premarket Friday

NeuroPace Prices $65 Million Offering; Shares Drop in Pre-Market

GuruFocus.com

7 months ago

NeuroPace Prices $65 Million Offering; Shares Drop in Pre-Market

MT Newswires

7 months ago

NeuroPace Prices $65 Million Public Offering

NeuroPace Announces Pricing of Public Offering of $65 Million of Common Stock

GlobeNewswire

7 months ago

NeuroPace Announces Pricing of Public Offering of $65 Million of Common Stock

MT Newswires

7 months ago

NeuroPace Plans $65 Million Public Offering; Shares Tumble After Hours

NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock

GlobeNewswire

7 months ago

NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock

NeuroPace Announces Upcoming Oral Presentation of Data from the Post-Approval Study of the RNS System at the American Academy of Neurology 2025 Annual Meeting Being Held April 5th – 9th

GlobeNewswire

7 months ago

NeuroPace Announces Upcoming Oral Presentation of Data from the Post-Approval Study of the RNS System at the American Academy of Neurology 2025 Annual Meeting Being Held April 5th – 9th

MT Newswires

8 months ago

NeuroPace Expects 2025 Revenue Growth

NeuroPace Issues 2025 Financial Guidance Targets

GlobeNewswire

8 months ago

NeuroPace Issues 2025 Financial Guidance Targets

NeuroPace (NPCE) Soars 9.1%: Is Further Upside Left in the Stock?

Zacks

8 months ago

NeuroPace (NPCE) Soars 9.1%: Is Further Upside Left in the Stock?

MT Newswires

8 months ago

NeuroPace Preliminary Q4 Revenue Increases; Shares Rise After Hours

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates

GlobeNewswire

8 months ago

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates

NeuroPace (NPCE) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

9 months ago

NeuroPace (NPCE) Upgraded to Buy: What Does It Mean for the Stock?

NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

9 months ago

NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference

NeuroPace to Host Investor Day on January 28th in New York City

GlobeNewswire

9 months ago

NeuroPace to Host Investor Day on January 28th in New York City

Wall Street Analysts Think NeuroPace (NPCE) Could Surge 31.47%: Read This Before Placing a Bet

Zacks

9 months ago

Wall Street Analysts Think NeuroPace (NPCE) Could Surge 31.47%: Read This Before Placing a Bet

NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting

GlobeNewswire

9 months ago

NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting

NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome

GlobeNewswire

9 months ago

NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome

What Makes NeuroPace (NPCE) a New Buy Stock

Zacks

10 months ago

What Makes NeuroPace (NPCE) a New Buy Stock

Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade

Zacks

10 months ago

Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade

NeuroPace Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

10 months ago

NeuroPace Third Quarter 2024 Earnings: Beats Expectations

GuruFocus.com

10 months ago

NeuroPace Inc (NPCE) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ...

NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates

Zacks

10 months ago

NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates

Associated Press Finance

10 months ago

NeuroPace Inc.: Q3 Earnings Snapshot

NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

GlobeNewswire

10 months ago

NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

Earnings To Watch: NeuroPace Inc (NPCE) Reports Q3 2024 Result

GuruFocus.com

10 months ago

Earnings To Watch: NeuroPace Inc (NPCE) Reports Q3 2024 Result

private equity firms who own 45% along with institutions invested in NeuroPace, Inc. (NASDAQ:NPCE) saw increase in their holdings value last week

Simply Wall St.

10 months ago

private equity firms who own 45% along with institutions invested in NeuroPace, Inc. (NASDAQ:NPCE) saw increase in their holdings value last week

NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy

GlobeNewswire

10 months ago

NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 10/30/2024

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 10/29/2024

KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares

GuruFocus.com

a year ago

KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares

Strength Seen in NeuroPace (NPCE): Can Its 5.1% Jump Turn into More Strength?

Zacks

a year ago

Strength Seen in NeuroPace (NPCE): Can Its 5.1% Jump Turn into More Strength?

KCK LTD. Adjusts Stake in NeuroPace Inc

GuruFocus.com

a year ago

KCK LTD. Adjusts Stake in NeuroPace Inc

NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024

GlobeNewswire

a year ago

NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024

KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares

GuruFocus.com

a year ago

KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares

KCK LTD. Reduces Stake in NeuroPace Inc

GuruFocus.com

a year ago

KCK LTD. Reduces Stake in NeuroPace Inc

NeuroPace Continues to Strengthen Management Team

GlobeNewswire

a year ago

NeuroPace Continues to Strengthen Management Team

KCK LTD. Reduces Stake in NeuroPace Inc

GuruFocus.com

a year ago

KCK LTD. Reduces Stake in NeuroPace Inc

NeuroPace Strengthens Management Team with Two Key Appointments

GlobeNewswire

a year ago

NeuroPace Strengthens Management Team with Two Key Appointments

NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences

GlobeNewswire

a year ago

NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences

NeuroPace to Participate in Upcoming Healthcare Conferences in September

GlobeNewswire

a year ago

NeuroPace to Participate in Upcoming Healthcare Conferences in September

NeuroPace (NPCE) Q2 Earnings Beat, '24 Sales View Up

Zacks

a year ago

NeuroPace (NPCE) Q2 Earnings Beat, '24 Sales View Up

NeuroPace Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a year ago

NeuroPace Second Quarter 2024 Earnings: Beats Expectations

Earnings Release: Here's Why Analysts Cut Their NeuroPace, Inc. (NASDAQ:NPCE) Price Target To US$14.57

Simply Wall St.

a year ago

Earnings Release: Here's Why Analysts Cut Their NeuroPace, Inc. (NASDAQ:NPCE) Price Target To US$14.57

MT Newswires

a year ago

NeuroPace's Q2 Net Loss Narrows, Revenue Rises

NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

GlobeNewswire

a year ago

NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

Waters (WAT) Q2 Earnings and Revenues Top Estimates

Zacks

a year ago

Waters (WAT) Q2 Earnings and Revenues Top Estimates

NeuroPace to Report Second Quarter 2024 Financial Results on August 13, 2024

GlobeNewswire

a year ago

NeuroPace to Report Second Quarter 2024 Financial Results on August 13, 2024

MT Newswires

a year ago

Morgan Stanley Lowers Price Target on NeuroPace to $8 From $9.50, Keeps Equalweight Rating

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

CNW Group

a year ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

a year ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

Business Wire

a year ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts

AFP

a year ago

New Zealand scraps plan to tax livestock burps, farts

Business Wire

a year ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

The Wall Street Journal

a year ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

UK Unemployment Rises in Sign Inflationary Pressures Cool

Bloomberg

a year ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Simply Wall St.

a year ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Share on Social Networks: